The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of <i>Lumican</i>

Quinoline derivatives have been reported to possess a wide range of pharmaceutical activities. Our group previously synthesized a series of quinoline compounds, in which compound 91b1 showed a significant anticancer effect. The purpose of this study was to evaluate the anticancer activity of compoun...

Full description

Bibliographic Details
Main Authors: Yuanyuan Zhou, Zhongguo Zhou, Dessy Chan, Po yee Chung, Yongqi Wang, Albert Sun chi Chan, Simon Law, Kim hung Lam, Johnny Cheuk On Tang
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/21/13181
_version_ 1797467906842296320
author Yuanyuan Zhou
Zhongguo Zhou
Dessy Chan
Po yee Chung
Yongqi Wang
Albert Sun chi Chan
Simon Law
Kim hung Lam
Johnny Cheuk On Tang
author_facet Yuanyuan Zhou
Zhongguo Zhou
Dessy Chan
Po yee Chung
Yongqi Wang
Albert Sun chi Chan
Simon Law
Kim hung Lam
Johnny Cheuk On Tang
author_sort Yuanyuan Zhou
collection DOAJ
description Quinoline derivatives have been reported to possess a wide range of pharmaceutical activities. Our group previously synthesized a series of quinoline compounds, in which compound 91b1 showed a significant anticancer effect. The purpose of this study was to evaluate the anticancer activity of compound 91b1 in vitro and in vivo, and screen out its regulated target. A series of cancer cell lines and nontumor cell lines were treated with compound 91b1 by MTS cytotoxicity assay and cell-cycle assay. In vivo anticancer activity was evaluated by a xenografted model on nude mice. Target prediction of 91b1 was assessed by microarray assay and confirmed by pancancer analysis. Relative expression of the target gene <i>Lumican</i> was measured by qRT-PCR. 91b1 significantly reduced tumor size in the nude mice xenograft model. <i>Lumican</i> was downregulated after 91b1 treatment. <i>Lumican</i> was proven to increase tumorigenesis in vivo, as well as cancer cell migration, invasion, and proliferation in vitro. The results of this study suggest that the anticancer activity of compound 91b1 probably works through downregulating the gene <i>Lumican.</i>
first_indexed 2024-03-09T19:00:25Z
format Article
id doaj.art-384bc1b3af204d0983562bdff5f5e625
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T19:00:25Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-384bc1b3af204d0983562bdff5f5e6252023-11-24T05:03:49ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-10-0123211318110.3390/ijms232113181The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of <i>Lumican</i>Yuanyuan Zhou0Zhongguo Zhou1Dessy Chan2Po yee Chung3Yongqi Wang4Albert Sun chi Chan5Simon Law6Kim hung Lam7Johnny Cheuk On Tang8School of Biomedical Engineering, Sun Yat-sen University, Guangzhou 510006, ChinaSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4032, AustraliaState Key Laboratory of Chemical Biology and Drug Discovery, Lo Ka Chung Centre for Natural Anticancer Drug, Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, ChinaState Key Laboratory of Chemical Biology and Drug Discovery, Lo Ka Chung Centre for Natural Anticancer Drug, Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, ChinaDepartment of Biosystems Science and Eng, Eidgenössische Technische Hochschule (ETH) Zürich, 4058 Basel, SwitzerlandSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, ChinaDepartment of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, ChinaState Key Laboratory of Chemical Biology and Drug Discovery, Lo Ka Chung Centre for Natural Anticancer Drug, Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, ChinaState Key Laboratory of Chemical Biology and Drug Discovery, Lo Ka Chung Centre for Natural Anticancer Drug, Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, ChinaQuinoline derivatives have been reported to possess a wide range of pharmaceutical activities. Our group previously synthesized a series of quinoline compounds, in which compound 91b1 showed a significant anticancer effect. The purpose of this study was to evaluate the anticancer activity of compound 91b1 in vitro and in vivo, and screen out its regulated target. A series of cancer cell lines and nontumor cell lines were treated with compound 91b1 by MTS cytotoxicity assay and cell-cycle assay. In vivo anticancer activity was evaluated by a xenografted model on nude mice. Target prediction of 91b1 was assessed by microarray assay and confirmed by pancancer analysis. Relative expression of the target gene <i>Lumican</i> was measured by qRT-PCR. 91b1 significantly reduced tumor size in the nude mice xenograft model. <i>Lumican</i> was downregulated after 91b1 treatment. <i>Lumican</i> was proven to increase tumorigenesis in vivo, as well as cancer cell migration, invasion, and proliferation in vitro. The results of this study suggest that the anticancer activity of compound 91b1 probably works through downregulating the gene <i>Lumican.</i>https://www.mdpi.com/1422-0067/23/21/13181quinolineanticancer<i>Lumican</i>microarray
spellingShingle Yuanyuan Zhou
Zhongguo Zhou
Dessy Chan
Po yee Chung
Yongqi Wang
Albert Sun chi Chan
Simon Law
Kim hung Lam
Johnny Cheuk On Tang
The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of <i>Lumican</i>
International Journal of Molecular Sciences
quinoline
anticancer
<i>Lumican</i>
microarray
title The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of <i>Lumican</i>
title_full The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of <i>Lumican</i>
title_fullStr The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of <i>Lumican</i>
title_full_unstemmed The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of <i>Lumican</i>
title_short The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of <i>Lumican</i>
title_sort anticancer effect of a novel quinoline derivative 91b1 through downregulation of i lumican i
topic quinoline
anticancer
<i>Lumican</i>
microarray
url https://www.mdpi.com/1422-0067/23/21/13181
work_keys_str_mv AT yuanyuanzhou theanticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT zhongguozhou theanticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT dessychan theanticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT poyeechung theanticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT yongqiwang theanticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT albertsunchichan theanticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT simonlaw theanticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT kimhunglam theanticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT johnnycheukontang theanticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT yuanyuanzhou anticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT zhongguozhou anticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT dessychan anticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT poyeechung anticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT yongqiwang anticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT albertsunchichan anticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT simonlaw anticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT kimhunglam anticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani
AT johnnycheukontang anticancereffectofanovelquinolinederivative91b1throughdownregulationofilumicani